- Global Pharma News & Resources

Global Drug Bioavailability Enhancement Summit 2023: Formulation and Delivery Technologies for Improving Drug Product Performance and Bioavailability (Princeton, NJ, United States - May 16-17, 2023) -

DUBLIN--(BUSINESS WIRE)--The "2023 Global Drug Bioavailability Enhancement Summit" conference has been added to's offering.

Connect with 160+ senior drug development innovators in Princeton, NJ this May for industry's leading drug product development Summit. Attend and uncover industry's latest formulation and delivery technologies for improving drug product performance and bioavailability.

Benefit from 30+ expert sessions and panels including:

  • Targeted and Modified Delivery
  • Model-Guided Formulation Design
  • Nucleic Acid Delivery for Enabling MRNA
  • Long-Acting Injectables - Biopharmaceutics & Product Design
  • Rational Design of Oral Formulation
  • Spray Conjealing to Enhance Bioavailability
  • Advancing IVIVC of Subcutaneous Bioavailability
  • MED 3D Printing for Oral Bioavailability
  • Selection of Membrane-Permeable Peptides
  • and many more sessions and panels

2022's Speakers Included:

Pratik Saha, PhD

Director, Biopharmaceutics, Pharmaceutical Development


Dipen Desai, PhD

Vice President, Complex Product Development


Arijit Chakravarty, PhD

Chief Executive Officer

Fractal Therapeutics

Manuel Sanchez-Felix, PhD

Senior Fellow, Novel Delivery Technologies

Novartis Institute for Biomedical Research

Ramesh Palaparthy, PhD

Executive Director, Clinical Pharmacology

Gilead Sciences

Wenzhan Yang, PhD

Senior Scientist, Pharmaceutical Development


Arul Joseph, PhD

Senior Director, CMC Pharmaceutical Dev

Otsuka Pharmaceuticals

Gillie Roth, PhD

Scientist, Preclinical & Translational PKPD


Mikhail Murashov, PhD

Senior Scientist, Preclinical Development

Merck & Co.

Hamsini Dhoolypala, PhD

Senior Associate Scientist, Pharmacokinetics


Debanjan Das, PhD

Senior Associate Director & Science Fellow


Ingrid Liu, PhD

Senior Scientist, Oral Formulation Sciences

Merck & Co.

Xiaoling Li, PhD

Co-Founder & CEO


Iriny Ekladious, PhD

Associate Principal Scientist, Sterile and Specialty Products

Merck & Co.

Santipharp Panmai, PhD

Vice President and Head of Early-phase Formulation Development


Nitin Swarnakar, PhD

North American Pharma Applications Manage


For more information about this conference visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 13-Dec-2022